MTII administered peripherally reduces fat without invoking apoptosis in rats

Physiology and Behavior

Volumn 79, Issue 2, 2003, Pages 331-337

  Choi, Yang Ho ^b   Li, ChangLong ^b   Hartzell, Diane L ^b   Lin, Ji ^b   Della Fera, Mary Anne ^b   Baile, Clifton A ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b NONE

Author keywords

Adipose apoptosis; Body temperature; Body weight; Food intake; Free fatty acids; Insulin; Leptin; Lipolysis; Melanocortin; Melanotan II

Indexed keywords

DNA FRAGMENT; HORMONE RECEPTOR STIMULATING AGENT; LEPTIN; MELANOCORTIN; MELANOCORTIN RECEPTOR; MELANOTAN II; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEHAVIOR; BODY TEMPERATURE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DRUG EFFECT; EPIDIDYMIS; FATTY ACID BLOOD LEVEL; FLUID INTAKE; FOOD INTAKE; LIPID METABOLISM; LIPID STORAGE; MALE; METABOLISM; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; RETROPERITONEUM; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

EID: 0037756752     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(03)00118-5     Document Type: Article

References (31)

1. MacNeil D.J., Howard A.D., Guan X., Fong T.M., Nargund R.P., Bednarek M.A.et al. The role of melanocortins in body weight regulation: opportunities for the treatment of obesity. Eur. J. Pharmacol. 440:2002;141-157.
2. Cone R.D. The ups and downs of leptin action. [editorial] [In Process Citation] Endocrinology. 140:1999;4921-4922.
3. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168.
4. Krude H., Biebermann H., Luck W., Horn R., Brabant G., Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19:1998;155-157.
5. Yaswen L., Diehl N., Brennan M.B., Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med. 5:1999;1066-1070.
6. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R.et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
7. Butler A.A., Kesterson R.A., Khong K., Cullen M.J., Pelleymounter M.A., Dekoning J.et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology. 141:2000;3518-3521.
8. Chen G., Koyama K., Yuan X., Lee Y., Zhou Y.T., O'Doherty R.et al. Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc. Natl. Acad. Sci. U. S. A. 93:1996;14795-14799.
9. Hamilton B.S., Doods H.N. Chronic application of MTII in a rat model of obesity results in sustained weight loss. Obes. Res. 10:2002;182-187.
10. Pierroz D.D., Ziotopoulou M., Ungsunan L., Moschos S., Flier J.S., Mantzoros C.S. Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes. 51:2002;1337-1345.
11. Hwa J.J., Ghibaudi L., Compton D., Fawzi A.B., Strader C.D. Intracerebroventricular injection of leptin increases thermogenesis and mobilizes fat metabolism in ob/ob mice. Horm. Metab. Res. 28:1996;659-663.
12. Adage T., Scheurink A.J., de Boer S.F., de Vries K., Konsman J.P., Kuipers F.et al. Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats. J. Neurosci. 21:2001;3639-3645.
13. Schwartz M.W., Woods S.C., Porte D. Jr., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature. 404:2000;661-671.
14. Cheung C.C., Clifton D.K., Steiner R.A. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology. 138:1997;4489-4492.
15. Cowley M.A., Smart J.L., Rubinstein M., Cerdan M.G., Diano S., Horvath T.L.et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 411:2001;480-484.
16. Satoh N., Ogawa Y., Katsuura G., Numata Y., Masuzaki H., Yoshimasa Y.et al. Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci. Lett. 249:1998;107-110.
17. Marsh D.J., Hollopeter G., Huszar D., Laufer R., Yagaloff K.A., Fisher S.L.et al. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat. Genet. 21:1999;119-122.
18. Cettour-Rose P., Rohner-Jeanrenaud F. The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats. Endocrinology. 143:2002;2277-2283.
19. Qian H., Azain M.J., Compton M.M., Hartzell D.L., Hausman G.J., Baile C.A. Brain administration of leptin causes deletion of adipocytes by apoptosis. Endocrinology. 139:1998;791-794.
20. Wang T., Hartzell D.L., Rose B.S., Flatt W.P., Hulsey M.G., Menon N.K.et al. Metabolic responses to intracerebroventricular leptin and restricted feeding. Physiol. Behav. 65:1999;839-848.
21. Shimabukuro M., Zhou Y.T., Levi M., Unger R.H. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. U. S. A. 95:1998;2498-2502.
22. Grill H.J., Ginsberg A.B., Seeley R.J., Kaplan J.M. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight. J. Neurosci. 18:1998;10128-10135.
23. Murphy B., Nunes C.N., Ronan J.J., Hanaway M., Fairhurst A.M., Mellin T.N. Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat. J. Appl. Physiol. 89:2000;273-282.
24. Hohmann J.G., Teal T.H., Clifton D.K., Davis J., Hruby V.J., Han G.et al. Differential role of melanocortins in mediating leptin's central effects on feeding and reproduction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:2000;R50-R59.
25. Thiele T.E., van Dijk G., Yagaloff K.A., Fisher S.L., Schwartz M., Burn P.et al. Central infusion of melanocortin agonist MTII in rats: assessment of c-fos expression and taste aversion. Am. J. Physiol. 274:1998;R248-R254.
26. Della-Fera M.A., Li C., Harris R.B., Baile C.A. Resistance to leptin-induced adipose apoptosis caused by high fat diet. Biochem. Biophys. Res. Commun. 303(4):2003;1053-1057.
27. Seeley R.J., Yagaloff K.A., Fisher S.L., Burn P., Thiele T.E., van Dijk G.et al. Melanocortin receptors in leptin effects. Nature. 390:1997;349.
28. Shimabukuro M., Higa M., Zhou Y.T., Wang M.Y., Newgard C.B., Unger R.H. Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J. Biol. Chem. 273:1998;32487-32490.
29. Gullicksen P.S., Hausman D.B., Dean R.G., Hartzell D.L., Baile C.A. Adipose tissue cellularity and apoptosis after intracerebroventricular injections of leptin and 21 days of recovery in rats. Int. J. Obes. 27(3):2003;302-312.
30. Forbes S., Bui S., Robinson B.R., Hochgeschwender U., Brennan M.B. Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway. Proc. Natl. Acad. Sci. U. S. A. 98:2001;4233-4237.
31. Huang Q.H., Hruby V.J., Tatro J.B. Systemic alpha-MSH suppresses LPS fever via central melanocortin receptors independently of its suppression of corticosterone and IL-6 release. Am. J. Physiol. 275:1998;R524-R530.